Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?

Eglen RM, Randle DH.

Assay Drug Dev Technol. 2015 Jun;13(5):262-5. doi: 10.1089/adt.2015.647. Epub 2015 Jun 29.

PMID:
26121065
2.

Label-free cell-based dynamic mass redistribution assays.

Gitschier HJ, Bergeron AB, Randle DH.

Curr Protoc Chem Biol. 2014 Mar 14;6(1):39-51. doi: 10.1002/9780470559277.ch130205.

PMID:
24652622
3.

A coupled chemical-genetic and bioinformatic approach to Polo-like kinase pathway exploration.

Snead JL, Sullivan M, Lowery DM, Cohen MS, Zhang C, Randle DH, Taunton J, Yaffe MB, Morgan DO, Shokat KM.

Chem Biol. 2007 Nov;14(11):1261-72.

4.
5.

Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.

Randle DH, Zindy F, Sherr CJ, Roussel MF.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9654-9. Epub 2001 Jul 31.

6.

p53-independent functions of the p19(ARF) tumor suppressor.

Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP.

Genes Dev. 2000 Sep 15;14(18):2358-65.

7.

Tumor spectrum in ARF-deficient mice.

Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ.

Cancer Res. 1999 May 1;59(9):2217-22.

8.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF.

Genes Dev. 1998 Aug 1;12(15):2424-33.

Supplemental Content

Loading ...
Support Center